Financhill
Back

Fennec Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24

FRX.TO
Fennec Pharmaceuticals, Inc.

Last Price:
$10.39
Seasonality Move:
17.23%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FRX.TO is experiencing slight buying pressure.

Fennec Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 10.51 Sell
20-day SMA: 10.72 Sell
50-day SMA: 11.34 Sell
200-day SMA: 10.84 Sell
8-day EMA: 10.49 Sell
20-day EMA: 10.75 Sell
50-day EMA: 11.21 Sell
200-day EMA: 10.95 Sell

Fennec Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.36 - 11.6) Sell
Bollinger Bands (100): (10.96 - 12.56) Sell

Fennec Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Fennec Pharmaceuticals, Inc. Stock

Is Fennec Pharmaceuticals, Inc. Stock a Buy?

FRX.TO Technical Analysis vs Fundamental Analysis

Sell
24
Fennec Pharmaceuticals, Inc. (FRX.TO) is a Sell

Is Fennec Pharmaceuticals, Inc. a Buy or a Sell?

Fennec Pharmaceuticals, Inc. Stock Info

Market Cap:
354.9M
Price in USD:
10.39
Share Volume:
0

Fennec Pharmaceuticals, Inc. 52-Week Range

52-Week High:
13.83
52-Week Low:
7.02
Sell
24
Fennec Pharmaceuticals, Inc. (FRX.TO) is a Sell

Fennec Pharmaceuticals, Inc. Share Price Forecast

Is Fennec Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Fennec Pharmaceuticals, Inc.

Is Fennec Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $1.25 per share.

Technical Analysis of Fennec Pharmaceuticals, Inc.

Should I short Fennec Pharmaceuticals, Inc. stock?

* Fennec Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.